Thema
prev ...
7GR28W0FJI
1
7XL5ISS668
1
8N3DW7272P
1
A+AVD therapy (brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine)
1
Acetylcysteine
1
Adenosine Monophosphate
1
Aerosols
1
Alanine
1
Antibodies, Antinuclear
1
Antibodies, Monoclonal, Humanized
1
Antibodies, Monoclonal, Murine-Derived
1
Antineoplastic Agents
1
Antineoplastic Agents, Immunological
1
Antitubercular Agents
1
Aplastic anemia
1
Barium Sulfate
1
Benzamidines
1
Brentuximab Vedotin
1
COVID-19
1
Carcinoembryonic antigen (CEA)
1
Classical Hodgkin lymphoma
1
Contrast Media
1
Cyclophosphamide
1
Cytokeratin 19 fragment
1
Cytokines
1
DA87705X9K
1
DPT0O3T46P
1
Dacarbazine
1
Danazol
1
EC 1.15.1.1
1
EC 2.7.10.1
1
EGFR protein, human
1
Epidermal growth factor receptor
1
ErbB Receptors
1
Erlotinib Hydrochloride
1
Estrogen Antagonists
1
Free Radical Scavengers
1
GAN16C9B8O
1
Gadolinium DTPA
1
Gefitinib
1
Glucocorticoids
1
Glutathione
1
Guanidines
1
Hydroxychloroquine
1
Immune-related adverse events
1
K2I13DR72L
1
Letter
1
Methylprednisolone
1
N29QWW3BUO
1
Nitric Oxide
1
mehr ...